Related Experiment Videos
[Chromosome aberrations in chronic myeloid leukemia]
1Katedry i Zakładu Patofizjologii AM, Wrocławiu.
Acta Haematologica Polonica
|January 1, 1992
Summary
The Philadelphia chromosome (Ph) is a marker for chronic myeloid leukemia, arising from genetic translocations. Secondary chromosomal aberrations, like trisomy 8, often precede blastic crisis and hold prognostic value.
Area of Science:
- Cytogenetics
- Hematology
- Oncology
Context:
- The Philadelphia chromosome (Ph) is a hallmark of chronic myeloid leukemia (CML).
- CML pathogenesis involves specific chromosomal translocations, primarily t(9;22).
- Secondary chromosomal aberrations frequently emerge before disease progression.
Purpose:
- To elucidate the significance of secondary chromosomal aberrations in CML.
- To correlate specific aberrations with clinical and hematological features.
- To understand the prognostic implications of these genetic changes.
Summary:
- The Philadelphia chromosome (Ph), resulting from t(9;22) or complex translocations, is a key cytogenetic marker in chronic myeloid leukemia.
- Common secondary aberrations include trisomy 8, isochromosome 17q, and additional Ph chromosomes.
- The presence of these secondary aberrations is linked to prognosis and specific clinical presentations.
Impact:
- Provides insights into CML progression and evolution.
- Highlights the prognostic value of secondary chromosomal aberrations.
- Aids in risk stratification and personalized treatment strategies for CML patients.